![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
THERAPEUTICAL NOTE
Chirurgia 2022 February;35(1):51-4
DOI: 10.23736/S0394-9508.21.05271-2
Copyright © 2021 EDIZIONI MINERVA MEDICA
language: English
Autologous micro-fragmented fat injection results in cases of complex perianal fistula in patients with Crohn’s disease
María J. SEGURA 1 ✉, Rafael ALÓS 2, Amparo SOLANA 1, Marina ALARCÓN 1, María D. RUIZ 1, Roberto LOZOYA 1
1 Hospital de Sagunto, Valencia, Spain; 2 Hospital La Fe, Valencia, Spain
BACKGROUND: The presence of complex perianal fistulas in Crohn’s disease (CD) determines important morbidity due to their difficult management, their high rate of recurrence and, in many cases, the failure of all available resources. It has been described that adipose tissue contains adult mesenchymal stem cells that can improve results in this type of patient. The aim of this study is to present our results of the adjuvant use of this therapy in complex perianal fistulas in patients with CD when other types of treatment have failed.
METHODS: Five patients with complex perianal fistulas and CD are presented, with a total of eight fistulas. In all cases, a curettage of the fistulous tract and closure of the internal fistulous orifice (IFO) was performed. Abdominal fat tissue was obtained by liposuction (180-210 mL) and processed with Lipogems™ device. Finally, 15-20 mL were obtained and injected around the IFO and the fistulous tract.
RESULTS: With an average follow-up of 22 months (9-35), complete healing has been obtained in six of the eight fistulas (75%), one of which is rectovaginal. In 25% of cases the fistula persists but there is no suppuration.
CONCLUSIONS: According to our results, injection of micro-fragmented and processed autologous fat with Lipogems™ device may be a valid treatment option for patients with CD and complex perianal fistula that do not respond to other therapies. Further studies and long-term follow-up are needed to confirm these results.
KEY WORDS: Rectal fistula; Mesenchymal stem cells; Crohn disease